arXiv · 2103.02643
Inference for natural mediation effects under case-cohort sampling with applications in identifying COVID-19 vaccine correlates of protection
Abstract
Combating the SARS-CoV2 pandemic will require the fast development of effective preventive vaccines. Regulatory agencies may open accelerated approval pathways for vaccines if an immunological marker can be established as a mediator of a vaccine's protection. A rich source of information for identifying such correlates are large-scale efficacy trials of COVID-19 vaccines, where immune responses are measured subject to a case-cohort sampling design. We propose two approaches to estimation of mediation parameters in the context of case-cohort sampling designs. We establish the theoretical large-sample efficiency of our proposed estimators and evaluate them in a realistic simulation to understand whether they can be employed in the analysis of COVID-19 vaccine efficacy trials.
Explore related subjects
Keep this discovery
David Benkeser, Iván Díaz, Jialu Ran. 2021-03-03. Inference for natural mediation effects under case-cohort sampling with applications in identifying COVID-19 vaccine correlates of protection. https://arxiv.org/abs/2103.02643
Cite the original work for its findings. Save a collection to share your selection of sources.